Autism committee, brain drain, dementia: Morning Rounds

0 3 minutes read

Former Top Fauci Adviser Indicted Regarding Covid Origins

David Morens, a former high-ranking official at the National Institute of Allergy and Infectious Diseases, was recently indicted on charges of concealing records from Freedom of Information Act requests. The indictment alleges that Morens hid and manipulated records to hinder discussions on the origins of the virus responsible for the Covid-19 pandemic, allegedly receiving kickbacks for his actions.

This development follows extensive congressional investigations into the Department of Health and Human Services’ management of the pandemic, particularly focusing on issues related to the virus’s origins. For further details on the indictment, refer to the coverage by STAT’s Washington team.

Reconvening of Autism Advisory Committee

The Interagency Autism Coordinating Committee, a federal advisory committee, held its first meeting in 19 months in Maryland. The committee, restructured by Health Secretary Robert F. Kennedy Jr. earlier this year with 21 new members, discussed the challenges in defining profound autism. This subgroup represents about a quarter of individuals on the autism spectrum, with distinct behaviors and needs requiring intensive care.

While the meeting began on a cordial note, it took a more intense turn as discussions delved into the unique requirements of individuals with profound autism. For a detailed account of the meeting, read the coverage by STAT’s O. Rose Broderick.

Concerns Over USDA Brain Drain in Food Safety

Recent announcements by the USDA regarding the relocation of approximately 200 positions within its Food Safety and Inspection Service have raised concerns among experts. The move, shifting roles from Washington, D.C. to several other states, is feared to cause a brain drain as experienced agency leaders may opt to leave rather than uproot their lives for the relocation.

Leading nutrition expert Marion Nestle provides context on the potential decline in productivity resulting from similar actions taken by the USDA in the past. The Consumer Federation of America also warns that the shift may impede necessary reforms in areas like Salmonella control. For more insights, refer to the analysis by Sarah Todd.

Health Care Inequities and Future Challenges

A recent report by the Commonwealth Fund on health care disparities among different racial and ethnic groups has prompted concerns among experts. While the report shows progress in reducing disparities, recent attacks on diversity, equity, and inclusion initiatives raise fears that these gains may be short-lived. Anil Oza’s analysis delves into the implications of these trends.

Prescription Trends for Antipsychotics in Dementia Patients

Despite the heightened risks associated with medications like antipsychotics for older adults, there has been a surge in prescriptions among seniors, particularly those with dementia. A study published in JAMA Network Open highlighted the disproportionate prescribing of these drugs in acute and post-acute care settings, with a significant portion initiated during clinical visits in these settings.

The study also revealed that a considerable number of patients continued taking these medications a year after initiation, emphasizing the need to address prescribing practices in acute care environments. Efforts to reduce these prescriptions should focus on these settings, as indicated by the study’s findings.

Supreme Court’s Deliberation on ‘Skinny Labeling’

The Supreme Court is set to hear arguments on the practice of “skinny labeling” employed by generic drug companies seeking regulatory approval. This tactic allows generic drugs to be marketed for specific uses without infringing on patented uses covered by brand-name medications.

While seemingly technical, the outcome of this case could have significant implications for drug pricing and patient outcomes. Experts warn that without the practice of skinny labeling, patients may face higher drug costs and prolonged access barriers to essential medications. Ed Silverman’s coverage provides insights into the potential impact of this legal dispute.